Akanda Prices $15M Offering at $1.38; Share Count Would Jump to 13.3M
AKAN is trading near its 52-week low of $1.17 (2.6% above the low) on light trading volume (0.1× avg).
Summary
Akanda set terms on its $15 million offering — 10.87 million shares at $1.38 — which would roughly quintuple the share count and, pro forma, restore Nasdaq equity compliance, at the cost of heavy dilution and $3 million earmarked for marketing.
Key Events · Financing and Capital Events · AKAN
-
Offering Terms Fixed at $1.38
Up to 10,869,565 common shares or pre-funded warrants at an assumed $1.38 (October 13, 2026 Nasdaq close) for $15.0 million gross; pre-funded warrants carry a $0.0001 exercise price with 4.99%/9.99% ownership caps.
-
Share Count Would Roughly Quintuple
2,388,212 shares outstanding as of October 13, 2026 would become 13,257,777 after the offering; new investors face $0.805 per share dilution against pro forma net tangible book value of $0.575.
-
Pro Forma Equity Clears Nasdaq Minimum
Pro forma shareholders' equity moves from $(6.93) million to $8.07 million, above the $2.5 million Nasdaq requirement the company must meet by December 13, 2026.
-
Fees and Use of Proceeds
1.5% underwriting discount plus up to $47,900 of reimbursements and ~$225,000 of expenses leave ~$14.55 million net; up to $3 million goes to IR Agency marketing and ~$575,000 to note interest and a First Towers loan.
Analysis · AKAN · Technology
Akanda has finalized terms on the $15 million offering first registered on October 1: 10,869,565 shares (or pre-funded warrants) at an assumed $1.38, the October 13 Nasdaq close, for roughly $14.55 million net. Relative to the company, the deal is transformative in size — post-closing shares outstanding would be 13,257,777 versus 2,388,212 today, and new buyers absorb $0.805 per share of dilution against a pro forma net tangible book value of $0.575. The cash is badly needed: Akanda reported $755,238 of cash at June 30, 2026, a $9.7 million working capital deficit, a going-concern warning, and a Nasdaq stockholders' equity deficiency with a December 13, 2026 cure deadline. Pro forma equity of $8.07 million would clear the $2.5 million minimum, so the raise doubles as the delisting fix. Offsetting that: up to $3 million of proceeds goes to IR Agency marketing rather than operations, and the company has opted out of Nasdaq's 20% shareholder-approval rule, so existing holders have no vote on the dilution.
How filings like this one have moved
In the 30 days to Oct 19, 2026, 37.9% of the 895 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.87%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AKAN was trading at $1.20 on NASDAQ in the Technology sector, with a market capitalization of approximately $3.2M. The 52-week trading range was $1.17 to $78.90. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.